BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 99,700 shares, a growth of 129.7% from the March 31st total of 43,400 shares. Based on an average daily trading volume, of 1,510,000 shares, the short-interest ratio is currently 0.1 days. Currently, 1.4% of the shares of the stock are sold short.

BioNexus Gene Lab Trading Up 1.7 %

Shares of NASDAQ:BGLC traded up $0.01 during midday trading on Friday, reaching $0.60. 30,981 shares of the company’s stock traded hands, compared to its average volume of 1,219,581. BioNexus Gene Lab has a 1 year low of $0.31 and a 1 year high of $17.88. The company has a fifty day simple moving average of $0.73 and a two-hundred day simple moving average of $0.61.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments.